Boston Scientific Working to Restore Shipments After Cyberattack

By Colin Kellaher


Boston Scientific, which last week reported that a cyberattack was hampering its ability to fill orders, said it hopes to resume some shipments this week.

Boston Scientific late Sunday said it is working expeditiously toward partial restoration in order to ship some products this week, adding that it expects ordering and shipping will ramp up to full capacity once it can demonstrate the restoration is fully operable.

The Marlborough, Mass., medical-technology company said it is able to take orders electronically and place them in a queue for future fulfillment.

Boston Scientific said the investigation into the global network disruption to some of its operating systems and business applications is continuing, and that it is working with CrowdStrike and other cybersecurity experts.

The company said it has seen no indication of unauthorized activity in its environment related to the incident since Aug. 25, and that the unauthorized activity is limited to certain on-premise systems, with no impact to its cloud-based systems and applications.


Write to Colin Kellaher at colin.kellaher@wsj.com


(END) Dow Jones Newswires

August 31, 2026 11:16 ET (15:16 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center